The Cerebrovascular Research Group has several active research projects, both on primary and secondary prevention as well as pre-hospital and in-hospital treatment of acute stroke. The group has broad interest in atherosclerosis, inflammation and acute stroke, including multi-modal imaging methods (MRI, PET, ultrasound). The group research aims to reduce incidence of stroke (biomarkers), reduce stroke severity (neuroprotection) and improve patient outcome (cognition and vascular dementia). The research includes both clinical and translational studies.
Systolic blood pressure at age 40 and cognitive function 25 years later: the Akershus Cardiac Examination (ACE) 1950 Study
J Hypertens, 41 (1), 132-139
Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study
J Stroke Cerebrovasc Dis, 32 (1), 106860 (in press)
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, 612 (7938), E7